Treatment of refractory chronic GVHD with rituximab: a GITMO study F Zaja, A Bacigalupo, F Patriarca, M Stanzani, MT Van Lint, C Fili, ... Bone marrow transplantation 40 (3), 273-277, 2007 | 204 | 2007 |
The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis U Gianelli, C Vener, A Bossi, I Cortinovis, A Iurlo, NS Fracchiolla, F Savi, ... Modern pathology 25 (9), 1193-1202, 2012 | 130 | 2012 |
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT M Vigano, C Vener, P Lampertico, C Annaloro, C Pichoud, F Zoulim, ... Bone marrow transplantation 46 (1), 125-131, 2011 | 118 | 2011 |
Presepsin (soluble CD14 subtype): reference ranges of a new sepsis marker in term and preterm neonates L Pugni, C Pietrasanta, S Milani, C Vener, A Ronchi, M Falbo, M Arghittu, ... PloS one 10 (12), e0146020, 2015 | 101 | 2015 |
First-line imatinib vs second-and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis C Vener, R Banzi, F Ambrogi, A Ferrero, G Saglio, G Pravettoni, M Sant Blood advances 4 (12), 2723-2735, 2020 | 100 | 2020 |
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis C Vener, NS Fracchiolla, U Gianelli, R Calori, F Radaelli, A Iurlo, ... Blood, The Journal of the American Society of Hematology 111 (4), 1862-1865, 2008 | 95 | 2008 |
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study L Botta, G Gatta, R Capocaccia, C Stiller, A Cañete, L Dal Maso, K Innos, ... The Lancet Oncology 23 (12), 1525-1536, 2022 | 92 | 2022 |
The Significance of Bone Marrow Biopsy and JAK2V617F Mutation in the Differential Diagnosis Between the “Early” Prepolycythemic Phase of Polycythemia Vera … U Gianelli, A Iurlo, C Vener, A Moro, E Fermo, P Bianchi, D Graziani, ... American journal of clinical pathology 130 (3), 336-342, 2008 | 82 | 2008 |
Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoieticbone marrow histology U Gianelli, C Vener, PR Raviele, A Moro, F Savi, C Annaloro, F Somalvico, ... Leukemia & lymphoma 47 (9), 1774-1781, 2006 | 79 | 2006 |
Oxidative stress is increased in primary and post− polycythemia vera myelofibrosis C Vener, C Novembrino, FB Catena, NS Fracchiolla, U Gianelli, F Savi, ... Experimental hematology 38 (11), 1058-1065, 2010 | 60 | 2010 |
VEGF expression correlates with microvessel density in Philadelphia chromosome–negative chronic myeloproliferative disorders U Gianelli, C Vener, PR Raviele, F Savi, F Somalvico, R Calori, A Iurlo, ... American journal of clinical pathology 128 (6), 966-973, 2007 | 59 | 2007 |
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status A Cortelezzi, G Gritti, N Del Papa, MC Pasquini, R Calori, U Gianelli, ... Leukemia 22 (3), 646-649, 2008 | 57 | 2008 |
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia C Vener, D Soligo, E Berti, U Gianelli, F Servida, E Ceretti, R Caputo, ... British journal of dermatology 156 (6), 1357-1361, 2007 | 53 | 2007 |
Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis C Vener, A Guffanti, M Pomati, M Colombi, A Aliettf, M Luis La targia, ... Leukemia & lymphoma 37 (3-4), 333-339, 2000 | 45 | 2000 |
Analysis of incidence, mortality and survival for pancreatic and biliary tract cancers across Europe, with assessment of influence of revised European age standardisation on … P Minicozzi, T Cassetti, C Vener, M Sant Cancer Epidemiology 55, 52-60, 2018 | 42 | 2018 |
Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy E Ferrazzi, S Zullino, T Stampalija, C Vener, P Cavoretto, MT Gervasi, ... Ultrasound in Obstetrics & Gynecology 48 (2), 224-231, 2016 | 40 | 2016 |
Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms L Boiocchi, C Vener, F Savi, E Bonoldi, A Moro, NS Fracchiolla, A Iurlo, ... Journal of clinical pathology 64 (3), 226-231, 2011 | 39 | 2011 |
Presepsin (Soluble cd14 subtype) as an early marker of neonatal sepsis and septic shock: A prospective diagnostic trial C Pietrasanta, A Ronchi, C Vener, C Poggi, C Ballerini, L Testa, ... Antibiotics 10 (5), 580, 2021 | 25 | 2021 |
Conjunctival hemorrhagic events associated with imatinib mesylate V Claudia, R Francesco, I Alessandra, C Mariangela, A Andrea, ... International journal of hematology 86, 390-393, 2007 | 25 | 2007 |
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study R De Angelis, E Demuru, P Baili, X Troussard, A Katalinic, MDC Lopez, ... The Lancet Oncology 25 (3), 293-307, 2024 | 18 | 2024 |